Komipharm International Co. Ltd (041960) — Capital Reinvestment Ratio
Latest as of December 2025:
1.95x
Komipharm International Co. Ltd (041960) has a Capital Reinvestment Ratio of 1.95x as of December 2025, meaning it reinvests 2% of its operating cash flow (₩946.94 Million) in capital expenditures (₩1.85 Billion). See 041960 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.95x
Capex / Operating Cash Flow
Operating Cash Flow
₩946.94 Million
KRW
Capital Expenditures
₩1.85 Billion
KRW
Data as of
Dec 2025
Most recent filing
Komipharm International Co. Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Komipharm International Co. Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Komipharm International Co. Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Komipharm International Co. Ltd from 2013 to 2024. For live market cap and broader valuation context, see 041960 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.45x | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.3% |
| 2020 | 65.70x | ₩25.20 Million | ₩1.66 Billion | ▲ +988.4% |
| 2019 | 6.04x | ₩950.79 Million | ₩5.74 Billion | ▼ -46.9% |
| 2017 | 11.37x | ₩235.64 Million | ₩2.68 Billion | ▲ +12.3% |
| 2016 | 10.13x | ₩1.21 Billion | ₩12.24 Billion | ▲ +59.8% |
| 2013 | 6.34x | ₩3.93 Billion | ₩24.93 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow